Chemed Shares Gain on Full-Year Outlook

Dow Jones
04/24
 

By Elias Schisgall

 

Shares of Chemed rose after the company lifted its full-year guidance following revenue growth in the company's hospice business.

Shares were up 10% to $421.25 in after-hours trading Thursday. The stock closed up 2.6% at $382.97, down 10% this year.

The company, which owns a hospice care provider and a plumbing and drain cleaning business, said it now expects full-year adjusted earnings between $24.00 and $24.75 a share, up from a previous range of $23.25 to $24.25 a share.

Analysts polled by FactSet are expecting $23.88 a share.

The outlook lift was driven by the improved performance of the company's hospice business, Vitas, as well as Chemed's share repurchases in the first quarter, the company said.

Chemed on Thursday reported a profit of $66.3 million, or $4.84 a share, down from its profit of $71.8 million, or $4.86 a share, a year earlier.

Stripping out certain one-time items, the company logged adjusted earnings of $5.65 a share. Analysts were expecting $5.30 a share.

Sales and service revenues rose to $657.5 million from $646.9 million a year prior. Analysts were anticipating $649.8 million.

Vitas revenue rose 3.1% to $420 million. Roto-Rooter, the company's plumbing and drain-cleaning business, posted revenue of $237.5 million, down 0.9% year over year.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

April 23, 2026 18:07 ET (22:07 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10